Johanna Mercier

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and call appearances connecting this person to public companies.

GILD

Current role

8 appearances Latest appearance 2026-08-04

RCUS

Current role

Board Member

NBIX

Current role

Board Member

2021-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Gilead Sciences, Inc. (GILD)	Chief Commercial and Corporate Affairs Officer	$1,182,269	—	$4,564,517	$1,299,976	$2,150,901	$102,980	$9,300,643
2024	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer	$1,148,038	—	$4,139,594	$1,300,029	$1,845,246	$176,158	$8,609,065
2023	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer	$1,114,035	—	$4,190,733	$1,299,966	$1,805,440	$176,580	$8,586,754
2022	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer	$1,081,471	—	$4,301,757	$1,612,496	$1,995,732	$244,997	$9,236,453
2021	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer	$1,050,428	—	$2,620,663	$1,012,485	$1,557,231	$311,790	$6,552,597
2020	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer	$1,059,135	$1,600,000	$2,042,265	$874,968	$1,980,300	$220,243	$7,776,911
2019	Gilead Sciences, Inc. (GILD)	Chief Commercial Officer Merdad V. Parsey, M.D., Ph.D.	$461,538	$1,250,000	$3,751,166	$1,750,097	$650,000	$186,585	$8,049,386

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.